INTRODUCTION
Members of the genus Aspergillus are fungi ubiquitously distributed from the Arctic region to the tropics sparing no materials or objects. The term aspergillus was first described by Micheli in 1729 (149) , and the first description of a human disease caused by aspergilli was made in 1847 (212) . The aspergilli have become increasingly important since then and have been implicated as the causative agents of a number of diseases in humans and other animals. The aspergilli are considered opportunistic pathogens, and a variety of underlying conditions including impaired immune status contribute to disease production. In addition, however, the duration and quantity of exposure to the organism are important determinants of host response, and selected forms of as-postoperative or posttraumatic complication or as a superinfection following antibiotic therapy or the insertion of prosthetic devices or indwelling catheters. Although neutropenia is the most common predisposing factor, infections have been reported in completely normal individuals, in some instances, following exposure to exceptionally high concentrations of Aspergillus conidia (1, 93, 151) .
In most patients, the clinical entities are distinct; in a few patients, however, two or more entities may coexist, or there may be progression from one to the other. Hence, no single classification of Aspergillus-induced diseases is entirely satisfactory. However, these diseases can be broadly classified according to the following clinical conditions: saprophytic colonization, including saprophytic bronchopulmonary aspergillosis and pulmonary aspergilloma; allergic diseases, including allergic asthma, allergic rhinitis, allergic sinusitis, hypersensitivity pneumonitis (HP), and ABPA, and systemic disease, i.e., IA.
CHARACTERISTIC FEATURES OF ASPERGILLUS-INDUCED DISEASES
Saprophytic Colonization Bronchopulmonary colonization. Bronchopulmonary colonization refers to organism infestation of airways without evidence of direct tissue damage. The most important factors predisposing to colonization of the respiratory tract with aspergilli or other fungi include chronic destructive pulmonary disease, prolonged use of broad-spectrum antibiotics, malnutrition, and debilitation. A high incidence of saprophytic colonization has also been demonstrated in patients with bronchial asthma, bronchiectasis, chronic bronchitis, cystic fibrosis, and primary ciliary dyskinesia syndrome (19, 20) . Some of these patients mount an immunologic response manifested by serum precipitins, immediate skin reactivity, and an Arthus skin reaction to Aspergillus antigen. Although aspergilli have been isolated from the respiratory tracts of such patients, no direct correlation with underlying pulmonary disease could be made. Thus, saprophytic colonization in its usual and uncomplicated form is not an infection in the strict sense. However, its presence could adversely affect the immune responsiveness in a host and may interfere with the diagnosis of various disease entities (21) .
Aspergilloma. Aspergilloma, also known as mycetoma or fungus ball, is a saprophytic manifestation of a fungus growing in a preformed and poorly drained lung space. In 1938, Deve coined the term aspergilloma to describe the mycetomalike lesion caused by Aspergillus species (48) . An intrathoracic cavity, whether bronchial, parenchymatous, or pleural, can become colonized by Aspergillus species if it communicates with the bronchial tree. Aspergillus species may grow in the preformed spaces in the lung for months or years without invading the wall or other tissues. Many pulmonary diseases favor the development of aspergillomas. The most common antecedent diseases are pulmonary tuberculosis with healed cavities and chronic pulmonary sarcoidosis with cystic spaces (31, 90) . Fungal balls may also develop in the presence of active pulmonary tuberculosis or in ectatic bronchi with accompanying ABPA (187, 232 (39, 232) . A chronic cough with the production of purulent sputum and generalized symptoms of fever, weight loss, and malaise are common in patients who are atopic. Patients with aspergilloma and concomitant ABPA may also demonstrate wheezing and tightness of chest.
Pulmonary aspergillomas can often be diagnosed by their characteristic appearance in roentgenographs (167) . The characteristic sign is an opacity occupying some or most of a round or ovoid cavity that is partially surrounded by a crescent-shaped patch of air. Aspergillomas most often are located in the upper lobes or the superior segment of lower lobes. Although they tend to be solitary, bilateral and multiple aspergillomas have been described (35, 165 (166) . However, the lack of sufficiently pure and reliable allergenic extracts poses a major problem in the development of in vivo and in vitro tests for diagnosis (256) .
Allergic rhinitis. The classical forms of nasal allergy, hay fever and allergic rhinitis, may develop in susceptible individuals on exposure to mold spores and mycelia (34) . Allergic rhinitis develops as a result of interaction of allergens and IgE fixed to specific mast cells in the epithelial surface of the nasal mucosa. This results in the release of a number of chemical mediators, including histamine, eosinophil and other chemotactic factors, leukotrienes, and prostaglandins, which contribute to the pathogenesis of the disease (53, 65, 94, 210) . Allergic rhinitis can occur as a seasonal or a nonseasonal disease. In addition to Aspergillus species, a variety of other fungi can also act as causative agents of allergic rhinitis. The symptoms and signs of fungus-induced allergic rhinitis are usually indistinguishable from those caused by the inhalation of pollen, dust, danders, and insect allergens. The clinical symptoms may include persistent or intermittent nasal obstruction, nasal discharge, pruritis, and eye irritation. On subsequent exposures to fungal spores, sneezing and nocturnal cough may develop. The diagnosis of allergic rhinitis is based on clinical history and IgE-mediated skin reactivity to appropriate aeroallergens. In vitro tests such as the radioallergosorbent test and paper radioimmunosorbent test are useful in the diagnosis (34, 53, 65, 94, 210, 218, 256) .
Allergic sinusitis. Sinus disease due to fungi includes several clinicopathological syndromes, including fungal ball production and allergic fungal sinusitis (32, 94, 137) . The pathophysiology of allergic sinusitis differs considerably from that of fungal mycetoma. Allergic fungal sinusitis, which occurs in atopic individuals, is chronic and affects multiple sinuses without tissue invasion. Several fungi have been implicated in allergic fungal sinusitis. The most important ones are Aspergillus, Curvularia, Alternaria, and Bipolaris species (32, 63, 94, 137) . Most affected individuals are young and atopic, and nasal polyposis, asthma, and rhinitis are the frequently noted symptoms (63) . Mucoid impaction ("allergic mucin"), resulting in plugs containing fragments of the fungi similar to those seen in the sputum plugs of patients with ABPA, is a consistently noticed feature in individuals with allergic sinusitis (94) . The sinus exudate may contain eosinophils, Charcot-Leyden crystals, epithelial cells, cellular debris, and abundant fungal hyphae. Radiological examination may show progressive thickening and clouding of several or all paranasal sinuses. The patients may show immediate and late cutaneous reactivity, precipitating antibodies to an appropriate fungal antigen, and markedly elevated levels of total and specific serum IgG and IgE antibodies (24, 32) .
HP. HP, or extrinsic allergic alveolitis, is caused by the exposure of susceptible individuals to a number of organisms. Included in this disease group are farmer's lung, bagassosis, and mushroom worker's lung, which result from occupational exposure to thermophilic actinomycetes present in hay, bagasse, and mushroom compost, respectively (94) . Contaminated heating or air-conditioning systems in residential and commercial buildings may result in ventilation system-induced pneumonitis (111) . These diseases result mostly from the inhalation of actinomycetes belonging to the genera Faenia and Thermoactinomyces. Among the fungi, Aspergillus and Penicillium species are commonly associated with HP (111) . The mode of onset of HP may be acute or insidious and probably is dependent on the intensity and duration of exposure to the responsible antigen. The acute form of HP may result from intermittent exposure to an antigenic source. Sensitization occurs following inhalation of antigens, and on subsequent exposures the patient develops characteristic symptoms usually 4 to 8 h after inhalation. The symptoms persist for up to 12 h and recovery is spontaneous. The recurrence occurs each time the patient is exposed to the antigens, and there are asymptomatic periods between exposures. In the untreated chronic form of HP, irreversible lung damage frequently occurs. Continuous exposure to the antigens may result in intense immunological inflammatory reaction in the lung. Lung biopsies often reveal interstitial fibrosis with granuloma formation and alveolar wall thickening due to infiltration of lymphocytes, plasma cells, and eosinophils. The most characteristic feature of HP is the universal presence of serum antibodies against offending antigens (94, 111) . The complexity and cross-reactivity of antigens and the variable immunological responses of patients to these antigens are the major limitations in the diagnosis of HP.
ABPA. Early reports of Aspergillus disorders, possibly ABPA and characterized by severe bronchitis accompanied by asthmatic symptoms, were given by Popoff in 1887 (175) and Hamman in 1927 (73 (26, 209, 226) . Although there is no special age or sex distribution for ABPA, the disease tends to affect younger people, with most cases occurring before the age of 40. The disease has been reported even in children of <2 years of age (89) . The clinical symptoms of an acute episode of ABPA should be differentiated from those of more chronic forms. The acute onset is characterized by severe asthma and wheezing, fever, malaise, weightloss, chest pain, and productive cough with blood-streaked sputum. As the disease becomes chronic, the patient develops bronchiectasis with production of copious purulent sputum. Patients may cough up green, brown, or often blood-tinged mucous plugs containing eosinophils, Charcot-Leyden crystals, and fungal elements.
The radiological findings are quite varied. The commonest finding is homogeneous or nonhomogeneous consolidation, with or without atelectasis, involving a segment or a lobe.
Generally, the upper lobes are involved (184) . The upperlobe infiltrates shift from one place to another as the disease progresses. Repeated episodes of ABPA result in edema of bronchial walls, their dilation, and their eventual destruction. Radiographically, these changes are manifested as thickening of the walls and saccular dilation. With multiple episodes, bronchiectasis, cavitation, atelectasis, and subsequent fibrosis may also develop. Because the chest X-ray and symptoms may not exclude the possibility of ABPA in some patients, and some patients with ABPA show no remarkable symptoms, procedures such as tomography or computerized tomography scanning may be essential for demonstrating bronchiectasis. These procedures usually reveal cylindrical or saccular bronchiectasis with distal sparing, which suggests a pattern of localized obstruction and inflammation resulting from mucus and mycelial plugs in the larger air passages (53, 152) . The administration of oral corticosteroids clears the mucoid impactions which are responsible for much of the radiological involvement in patients with ABPA.
(ii) Diagnostic criteria of ABPA. ABPA has been described as an immunological disease that ranges from asthma to fatal destructive lung disease with defined clinical, serological, radiological, and pathological features (64, 66, 156, 157, 159, (84) . Since then, a number of additional features of ABPA have been recognized (49) . The diagnostic criteria have been revised several times and elaborated upon since their initial description (21, 65, 145, 158, 185) . The diagnosis of ABPA depends on central bronchiectasis and the presence or absence of chest roentgenographic infiltrate. The criteria are listed in Table 1 . Patients in whom proximal bronchiectasis is not detected by radiological procedures are designated ABPA-S (for seropositive), and those with central bronchiectasis are designated ABPA-CB. These designations combined with currently available serodiagnostic methods aid in the early diagnosis of ABPA (65) .
According to Greenberger and Patterson, ABPA should be ruled out in all patients with chronic asthma (67). Although the classic patients meet the criteria for ABPA, other suspected patients should be evaluated over a period of time (65, 72, 125, 181) . After being tested with A. fumigatus extracts, patients usually manifest dual cutaneous reactivity that consists of a wheal and erythema reaction within 10 to 20 min and erythema and induration (without a wheal) in 4 to 8 h. A dual response following bronchial provocation with A. fumigatus and production of sputum plugs containing hyphae are the characteristic features of a classic patient with ABPA (146) . A different set of diagnostic criteria was used by Sandhu et al. in their study (190) . They considered asthma, dual cutaneous reactions to A. fumigatus, recurrent roentgenographic infiltrates, elevated peripheral blood eosinophilia, positive sputum culture, and precipitins to A. fumigatus as diagnostic. These criteria would identify only the classic cases and miss the early cases of ABPA and cases of ABPA in remission.
ABPA should be ruled out in patients with chronic asthma exhibiting immediate reactivity to A. fumigatus or other Aspergillus antigens. Most of these patients demonstrate a 3+ to 4+ skin prick test response and will not require an intracutaneous injection. Although an elevated level of total serum IgE is suggestive, it is not specific for ABPA. The roentgenographic consolidation resulting from bacterial pneumonia can be differentiated from that of pulmonary infiltrates of ABPA (66) . Posterior segments of upper lobes are often affected, simulating tuberculosis, but middle and lower lobes have also been involved. The possibility of ABPA should also be considered in patients with a history of surgical resection for bronchiectasis (66) . There are also reports of ABPA-like syndromes caused by Curvularia, Candida, and Helminthosporium species and other fungi (5, 65, 71, 83) . Skin tests and tests for precipitins to A. fumigatus may be negative in these cases, whereas the culture of sputum or the presence of precipitins to other fungi may aid in specific diagnosis.
Systemic disease
IA. Although IA has been considered an infection exclusively of immunocompromised patients, sporadic cases have been reported even in normal hosts (1, 93, 151) . Infection is common in patients with leukemia and other hematological malignancies, in patients undergoing organ transplantation, and in chronic granulomatous disease of childhood (17, 29, 148, 176, 177) . The association of IA with AIDS is still controversial in spite of the few reported cases (43, 62 ). An increased prevalence of IA has been noted in bone marrow transplant recipients (42, 168, 251) . Predisposing factors for the development of IA in immunocompromised patients are manifold. They include neutropenia, granulocytopenia, underlying chronic diseases, and treatments such as those with corticosteroids, broad-spectrum antibiotics, and cytotoxic drugs (3, 54, 59, 70) . The IA detected in apparently healthy individuals may be due to unrecognized subtle immunological defects, tissue damage, viral infections, or antibiotic therapy for a bacterial infection (30) . Several recent nosocomial outbreaks of IA that occurred among leukemic patients and renal transplant recipients have been attributed to a variety of environmental sources. The potential sources of Aspergillus conidia from contaminated environments included hospital renovations, road constructions, and fireproofing materials. A. fumigatus conidia from contaminated air conditioners have been implicated in a number of cases of IA (4, 11, 126, 191) .
The pathogenesis of IA is complex. The lung serves as the portal of entry for the fungus, and colonization of the respiratory tract is followed by endobronchial proliferation and bronchial ulceration. The fungus may spread to the lung parenchyma, resulting in necrotizing bronchopneumonia, lobar pneumonia, or hemorrhagic infarction. An alternative route of colonization is through necrotic lung tissue following pulmonary emboli or bacterial infection or from the cavitary growth. As a result, single or multiple abscesses may be formed, in which case the diagnosis is made only at autopsy. Hematogenous spread from sites such as the gastrointestinal tract or intravenous catheters results in multiple miliary microabscesses throughout all organs (154, 155, 253) .
The symptoms of IA are mostly nonspecific. They include cough, wheezing, dyspnea, and fever. In Aspergillus-induced bronchitis, the chest radiograph may be normal, but single or multifocal nodules can be seen in established invasive disease. These nodules may undergo infarction or cavitation and appear often as bilateral consolidations (155) . The widespread radiological infiltrates give an indication of how extensively the disease has spread. The differential diagnosis of IA includes infections such as those due to Pneumocystis caring or Nocardia, Candida, Mycobacterium, or Mycoplasma species as well as some of the common bacterial infections. Humoral Immune Response Humoral immune responses in patients with ABPA and aspergilloma have been well studied. Sera from patients with ABPA consistently demonstrate high levels of A. fumigatusspecific circulating antibodies of the IgG and IgE isotypes (130, 185) . Specific antibodies belonging to other immunoglobulin classes have also been reported in these patients. According to Brummund et al., in addition to elevated levels of IgE and IgG antibodies, there was evidence of polyclonal elevation of levels of all immunoglobulin isotypes in patients with Aspergillus-induced diseases (33) . In a recent study, Kurup et al. showed that, along with all immunoglobulin isotypes, levels of subclasses of IgG, particularly IgG1 and IgG2, are also elevated in ABPA patients (120) . Similarly, A. fumigatus-specific antibodies belonging to the IgG class of immunoglobulins have been reported to be the predominant antibody isotype in patients with aspergilloma (240) . Recently, we have demonstrated that A. fumigatus-specific IgGl is the predominant subclass of IgG in patients with aspergilloma (120) .
Specific humoral responses differ considerably in patients with different clinical forms of aspergillosis because of the participation of diverse antigens of A. fumigatus (21, 65, 240) . Serum antibodies in patients with ABPA frequently react with protein antigens of A. fumigatus. Identical levels of A. fumigatus-specific antibodies belonging to the IgG1 and IgG2 subclasses are usually found in the sera of these patients (120) . Although aspergilloma patients frequently react to carbohydrate and glycoprotein antigens of A. fumigatus, their sera show more IgG1 than IgG2 subclasses. The characteristic expression of A. fumigatus-specific antibodies in the sera of patients with ABPA and aspergilloma suggests a difference in the fundamental immunoregulatory response to Aspergillus antigens in these disorders.
Cellular Immune Response Lymphocytic infiltration and granuloma formation in the lung clearly demonstrate the presence of a cell-mediated immune response in ABPA patients (208) . In some studies of A. fumigatus antigen-induced lymphocyte proliferation in ABPA patients, no correlation with disease activity was detected. In addition, proliferation was not significantly higher in ABPA patients than in patients with a positive immediate skin test reaction to A. fumigatus (77, 211) . These findings suggest that T-lymphocyte sensitization is not an important feature of ABPA. The lack of lymphocyte stimulation reported in these studies may be due to the use of less relevant antigens or to the treatment of the patients with prednisone. In contrast, other reports indicate that antigeninduced lymphocyte transformation can be demonstrated in patients with ABPA (57, 104, 234, 235 ). An antigen-induced proliferative response of lymphocytes from these ABPA patients has been correlated with disease activity. During the exacerbation of disease, the proliferative response of peripheral blood lymphocytes was undetectable. Analysis of peripheral blood by lymphocyte phenotyping demonstrated a significant increase in T-helper or inducer cells, whereas the suppressor cell population was normal (104) . Antibodydependent, cell-mediated cytotoxicity has also been reported in both ABPA and aspergilloma (117) .
The pathogenesis of ABPA is not completely understood. The host immunological response presumably is exaggerated in terms of specific antibody isotype, total serum IgE production, sensitized lymphocytes, cellular hyperreactivity, and complement activation in the bronchoalveolar compartment. Studies of cell-mediated immunity in Aspergillusinduced diseases are conflicting. The limited knowledge and conflicting results of studies on cell-mediated immune responses in patients with ABPA may be due partly to the lack of pure, dependable, and reproducible antigens. Studies with purified antigens would be of value in understanding both humoral and cell-mediated arms of immune response in aspergillosis. In contrast, the lymphokines and the cellmediated mechanisms by which T cells participate in the regulation of IgE synthesis and eosinophil activation and differentiation in certain other allergic diseases have been well documented (99, 231 (6, 124, 190 (80, 82, 115, 132, 172, 194, 197, 249 (74, 115, 122, 197, 248, 250) . On the other hand, in IA, galactomannan and glycoproteins are the major circulating antigens (25, 50, 179 (101, 114, 228, 229) . From the available reports it can be concluded that the most reliable cell-associated antigens for immunoassay can be obtained from 4-day-old growth of A. fumigatus in aerated cultures. Reliable culture filtrate antigen for immunoassays can be obtained from 2-to 4-week-old stationary cultures of the organism. The number of antigenic components is higher during the first 4 days but decreases as time goes on until the cell components are liberated into the medium after 2 to 4 weeks (101, 114, 228, 229) . Medium with an initial pH of about 5 consistently gave good results. Glucose-asparagine or a mixture of Czapek-AOAC broth (Difco) is the most widely accepted medium for the best growth of A. fumigatus (101, 114 (222) (223) (224) (225) . Of the 18 antigens showing enzyme activity, 13 reacted specifically with sera from patients with aspergillosis. Biguet et al. demonstrated antigen fractions having chymotryptic activity that specifically reacted with sera from patients with aspergilloma but not with sera from patients with ABPA (27) . A fraction having a molecular weight of 250,000, probably a tetramer demonstrating catalase activity, has been reported by Schonheyder et al. (200) . This fraction had sugar subunits with affinity to concanavalin A (ConA) and was detected in 13 of 14 clinical isolates of A. fumigatus. However, this component with catalase activity was also shared by other Aspergillus species and has not been clinically evaluated. Antibodies to catalase antigen have been found in patients with cystic fibrosis having ABPA (199) . Fractions with protease activity have been reported from both pathogenic and nonpathogenic species of Aspergillus. Schonheyder and Andersen partially purified a 25-to 50-kDa protease fraction having reactivity with patient sera (197) . We have isolated two acid proteases from membrane vesicles of A. fumigatus. The molecular weights of these fractions were 73,000 and 43,000. Both fractions bound to ConA and showed reactivity with sera from patients with ABPA in a biotin-avidin-linked immunosorbent assay (BALISA) (172) .
Polysaccharide fractions from either cell wall or cytoplasm show reactivity with specific antibodies. However, these antigens frequently demonstrate cross-reactivity with other fungal antigens. Galactomannan, with a molecular weight of 50,000 or more, has been purified by Azuma et al. It showed both skin test reactivity and a precipitin reaction (13) (14) (15) (16) . These authors also characterized and purified a galactomannan peptide complex by using a Sephadex G-200 column. This galactomannan has been identified as the significant circulating antigen in patients with IA (25, 50, 179 (74, 76, 123, 196, 248) . These antigens have been isolated from both culture filtrate and mycelial extracts of A. fumigatus (100, 204, 246, 249, 256) . Wilson and Hearn fractionated mycelial extracts by preparative isoelectric focusing and compared the reactivity of the three major fractions with that of crude water-soluble extracts (248) . They found that all fractions reacted with sera from patients with aspergillosis but also showed crossreactivity with antibodies against other fungi. By using preparative isoelectric focusing and affinity chromatography, we have isolated two fractions, one a glycoprotein and the other a protein (123) . In an ELISA, both fractions demonstrated reactivity against patient sera. We have also isolated another fraction which focused at pH 6.5 and showed 20-, 40-, and 80-kDa components in two-dimensional electrophoresis. This fraction also showed good reactivity with both IgE and IgG antibodies (116) . Longbottom and associates characterized four antigens (Ag 3, Ag 5, Ag 7, and Ag 13) by using gel filtration, isoelectric focusing, and affinity chromatography (74-76, 132, 134, 135, 219 we have isolated a fraction with two components of 35 and 65 kDa. This fraction consistently showed binding to IgG and IgE antibodies in sera from patients with ABPA (118) .
Using gel filtration, ConA affinity chromatography, isoelectric focusing, and trichloroacetic acid precipitation, Kauffman et al. obtained several antigen fractions from A. fumigatus (97) . They observed that the low-molecularweight (5,000 to 28,000) fraction usually demonstrated weak linkage to the polystyrene surface used in ELISA and gave weak precipitins. In contrast, high-molecular-weight components reacted strongly in the ELISA and precipitin tests. Longbottom found that low-molecular-weight peptides showed strong IgE-binding capacity and were more specific in the diagnosis of allergic aspergillosis (131) .
Monoclonal antibodies produced against Aspergillus species will be of value in purifying the relevant Aspergillus antigens (55, 109, 110, 215) . Using several such monoclonal antibodies, we purified antigens by employing monoclonal antibody affinity chromatography. Some of these antigens showed both IgE-and IgG-binding activities and will be of use in immunodiagnosis (109, 110 ID. Because of its simplicity and ease of performance, immunodiffusion (ID) is still the most widely used technique for the serodiagnosis of aspergillosis. Several investigators have highlighted its usefulness in demonstrating precipitin arcs in agar gels as a diagnostic tool for aspergillosis (18, 19, 40, 113, 122, 123, 136, 140, 170, 239) . Antigens used in ID may be extracts from mycelia or culture filtrates, which should be free of C-reactive substance (136) . Concentrating the serum specimens before testing may yield better results without reduction in specificity (137) . However, the ID test lacks sensitivity and gives no quantitative information on antibody concentrations. A micromodification of Wadsworth's agar gel diffusion technique has been used in our laboratory for testing antibodies in the sera of patients against a panel of antigens (52) . This method yielded reproducible results and has correlated well with other diagnostic methods, although the sensitivity is much lower than that of ELISA or RIA.
Immunogold assay. An (150) . Schonheyder and Andersen studied the reactivities of three antigen fractions of molecular weights 470,000, 250,000, and 25,000 to 50,000 (197) . The 470,000-molecular-weight fraction reacted with most sera from normal controls and patients with nonfungal lung diseases. The antibody response in aspergillosis patients was much stronger against this fraction than against control sera. When the 250,000-molecular-weight antigen was used in ELISA to test the sera from patients with aspergilloma, 13 Immunoblotting. Several studies have shown that glycoprotein antigens, a major constituent of both the mycelium and the culture filtrate of A. fumigatus, have high immunological reactivity (23, 74, 115, 197, 246, 250) . These antigens can be characterized by their molecular size, isoelectric points, ability to bind to ConA or other lectins, and enzymatic activity. The reactivity of specific components of A. fumigatus antigens to specific antibodies in the sera of patients can be studied by immunoblotting. This method involves the separation of denatured antigens in polyacrylamide gel followed by transfer onto nitrocellulose membranes. The reactivity of such antigens with antibody in the sera of patients can be visualized by the color reaction. Immunoblotting has been used with great success in detecting specific antibodies to Aspergillus species. The detailed methods of immunoblotting for the demonstration of anti-A.
fumigatus IgG and IgE in the sera of patients with aspergillosis have been reported (115) .
Several other diagnostic procedures that have also been developed for detecting aspergillosis include immunoelectrophoresis, passive hemagglutination, IIF, latex agglutination, complement fixation, and enzyme-linked immunofiltration assay (7, 22, 45, 58, 60, 61, 85, 87, 88, 95, 112, 129, 130, 139, 147, 173, 193, 195, 198, 201-203, 237, 238, 252) .
Several types of immunoelectrophoretic techniques have been used in diagnosing aspergillosis. Among these, counterimmunoelectrophoresis has been widely used, mainly because of the short time required to obtain results with this test. By using counterimmunoelectrophoresis, Longbottom could detect precipitins in 78% of patients with allergic aspergillosis; the ID test was positive in only 64% of the same cases (129) . However, compared with that for ID, the improved efficacy of immunoelectrophoresis has not been demonstrated because of the lack of specificity due to an increased number of false-positive results (112, 139, 147) . Crossed immunoelectrophoresis and crossed radioimmunoelectrophoresis have been reported to have added significance in the demonstration of A. fumigatus-specific antibodies. By using an intermediate gel and a reference serum, over 40 specific precipitin arcs have been detected (95, 130 (95, 200) , but these techniques are not often used because of the lengthy and cumbersome procedures. The occasional failures of these methods have been related to either a shortcoming in the techniques or the nonprecipitating nature of antigen-antibody complexes (95, 241) .
Apart from the use of immunoelectrophoresis in the characterization of antigens, the use of other tests is fairly limited because of factors such as false positivity, instability of antigen-treated erythrocytes, and the recent availability of more versatile and more sensitive detection methods. While the ID test and ELISA are the most widely used serodiagnostic methods in diagnosing aspergillosis, immunoblotting has the advantage of revealing additional characteristics of the relevant and reactive antigens.
Skin Tests
Skin test reactivity to Aspergillus antigen extracts is widely used to screen patients with suspected ABPA, in whom at least two types of skin reactions can be observed. The type I (immediate) reaction consists of cutaneous wheall and flare" within 15 to 20 min of skin test challenge. A type III reaction, or the Arthus reaction, can be seen as an induration usually developing by 4 to 10 h after skin testing. This reaction subsides after 24 h, but occasionally a delayed reaction, which might persist for 72 h or more, can also be seen. In patients with allergic asthma, only the immediate reaction is visible, whereas some aspergilloma patients having concomitant ABPA demonstrate both immediate and late skin test reactivities. A delayed-type skin test reactivity may also be present in patients with HP.
Detection of Circulating Antigens for Diagnosis of IA Aspergillosis is a major infection in patients with underlying diseases and other predisposing factors such as organ transplantation. The mortality of IA is very high and can be substantially reduced if an early diagnosis is made. Such a diagnosis is often difficult because major clinical symptoms are nonspecific and blood cultures are usually negative. Bronchoscopy and biopsy of the lung and involved organs are essential for diagnosis, but these invasive procedures have their own associated risks and high rates of falsenegative results (91) . Interest in developing rapid serological methods for the diagnosis of this disease has therefore increased.
The usual serological studies have not been useful in the diagnosis of IA. Because of the unusual predisposition of patients with IA, namely, lack of a functionally normal immune system because of malignancy or intentional immunosuppression as in organ transplantation, there is very little or no antibody response in these patients. Even so, all previous reports have dealt with the detection of Aspergillus-specific antibodies in the sera and body fluids of IA patients. Young (60, 68, 86, 143, 144, 148, 192) . When success in demonstrating specific antibodies against Aspergillus spp. has been reported, it has not received widespread recognition because of the lack of reli- (47, 50, 169, 179, 180, 206, 217, 243) . The methods used were ID, ELISA, and RIA. The sensitivity of these earlier methods was not sufficient to allow an early diagnosis. However, they were instrumental in the development of more refined assays for demonstrating antigenemia in patients. Recently, Western blotting (immunoblotting) has been used to detect circulating antigens in the sera and urine of rats with experimental IA (254) . Van Cutsem et al. used a commercially available latex agglutination test in experimental invasive aspergillosis in guinea pigs. The test had a 97.6% sensitivity in detecting circulating galactomannan in the plasma samples from those animals. The kit was tested with human sera and was positive in 13 of 15 proven cases and 17 of 18 patients with a high probability of invasive aspergillosis (227) .
A number of investigators have evaluated methods for detecting A. fumigatus antigens in the bronchoalveolar lavage fluid, sera, and urine of patients with aspergillosis (9, 50, 58, 78, 91, 186, 205, 244, 245, 250, 255) . The recent reports on the detection of antigenemia are summarized in Table 3 . Weiner and associates used competitive binding RIA for detecting cell wall carbohydrates and found antigenemia in 78% of the patients with aspergillosis and leukemia (244) . Other investigators used inhibition ELISA to quantitate specific antigens in the sera of patients with aspergillosis and of those predisposed to aspergillosis (50, 56, 183, 186, 250 (91) . In this assay, the antigens detected were mostly heat-resistant glycoproteins. Using polyclonal antibodies, Haynes and associates detected antigens in the urine of all 10 of their patients with aspergillosis and in 23 neutropenic patients with no evidence of aspergillosis. However, no reaction was found when monoclonal antibody against galactomannan was used (78) .
The success in detecting antigenemia in a patient's serum mainly depends on the frequent monitoring of samples (78, 242, 244, 250 
